235 related articles for article (PubMed ID: 15544740)
1. [Consensus document on the treatment of ascites, dilutional hyponatremia and hepatorenal syndrome in liver cirrhosis].
Ginès P; Cabrera J; Guevara M; Morillas R; Ruiz del Arbol L; Solàe R; Soriano G
Gastroenterol Hepatol; 2004 Nov; 27(9):535-44. PubMed ID: 15544740
[No Abstract] [Full Text] [Related]
2. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.
European Association for the Study of the Liver
J Hepatol; 2010 Sep; 53(3):397-417. PubMed ID: 20633946
[No Abstract] [Full Text] [Related]
3. [Treatment of ascites, hyponatremia and hepatorenal syndrome in liver cirrhosis].
Ackermann D
Ther Umsch; 2009 Nov; 66(11):747-51. PubMed ID: 19885792
[TBL] [Abstract][Full Text] [Related]
4. Ascites and hepatorenal syndrome: pathogenesis and treatment strategies.
Ginès P; Arroyo V; Rodés J
Adv Intern Med; 1998; 43():99-142. PubMed ID: 9506180
[No Abstract] [Full Text] [Related]
5. Treatment of the hepatorenal syndrome and hyponatremia in cirrhosis - part II.
Møller S; Aagaard NK; Schmidt L; Grønbaek H; Hansen JB; Bendtsen F
Dan Med J; 2012 Jan; 59(1):C4372. PubMed ID: 22239848
[TBL] [Abstract][Full Text] [Related]
6. Chinese guidelines on the management of ascites and its related complications in cirrhosis.
; Xu X; Duan Z; Ding H; Li W; Jia J; Wei L; Linghu E; Zhuang H
Hepatol Int; 2019 Jan; 13(1):1-21. PubMed ID: 30656520
[TBL] [Abstract][Full Text] [Related]
7. [Influence of circulatory dysfunction on the treatment of ascites and hepatorenal syndrome: vasoconstrictor and diuretic drug treatment].
Torre A; Terra C; Guevara M; Ginès P
Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():8-14. PubMed ID: 15195529
[No Abstract] [Full Text] [Related]
8. Hyponatremia in cirrhosis.
Sigal SH
J Hosp Med; 2012 Apr; 7 Suppl 4():S14-7. PubMed ID: 22489081
[TBL] [Abstract][Full Text] [Related]
9. [Dilutional hyponatremia, hepatorenal syndrome and liver transplantation].
Cárdenas A; Ginès P
Gastroenterol Hepatol; 2008 Jan; 31(1):29-36. PubMed ID: 18218278
[TBL] [Abstract][Full Text] [Related]
10. Minimizing ascites. Complication of cirrhosis signals clinical deterioration.
Garcia N; Sanyal AJ
Postgrad Med; 2001 Feb; 109(2):91-6, 101-3. PubMed ID: 11272697
[TBL] [Abstract][Full Text] [Related]
11. [Guidelines on the management of ascites in cirrhosis (2023 version)].
Chinese Society of Hepatology, Chinese Medical Association
Zhonghua Gan Zang Bing Za Zhi; 2023 Aug; 31(8):813-826. PubMed ID: 37723063
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome.
Khan S; Linganna M
Cleve Clin J Med; 2023 Apr; 90(4):209-213. PubMed ID: 37011958
[TBL] [Abstract][Full Text] [Related]
13. Management of ascites and hepatorenal syndrome.
Piano S; Tonon M; Angeli P
Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
[TBL] [Abstract][Full Text] [Related]
14. β-blockers and refractory ascites in cirrhosis: the message of a team of true scientists.
Angeli P
J Hepatol; 2011 Oct; 55(4):743-4. PubMed ID: 21396970
[No Abstract] [Full Text] [Related]
15. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.
Arroyo V; Ginès P; Gerbes AL; Dudley FJ; Gentilini P; Laffi G; Reynolds TB; Ring-Larsen H; Schölmerich J
Hepatology; 1996 Jan; 23(1):164-76. PubMed ID: 8550036
[No Abstract] [Full Text] [Related]
16. [Sodium restriction or supplement on cirrhotic patients with ascites].
Liu JJ
Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):317. PubMed ID: 19572469
[No Abstract] [Full Text] [Related]
17. [Hepatorenal syndrome: terminal stage of major complicances of hepatic cirrhosis].
Costantino S
Clin Ter; 2004 Sep; 155(9):361-2. PubMed ID: 15700628
[No Abstract] [Full Text] [Related]
18. [Physiopathology of refractory ascites and the hepatorenal syndrome].
Arroyo V
Nefrologia; 2002; 22 Suppl 5():41-6. PubMed ID: 12107916
[No Abstract] [Full Text] [Related]
19. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.
Arroyo V; Jiménez W
J Hepatol; 2000; 32(1 Suppl):157-70. PubMed ID: 10728802
[TBL] [Abstract][Full Text] [Related]
20. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.
Salerno F; Guevara M; Bernardi M; Moreau R; Wong F; Angeli P; Garcia-Tsao G; Lee SS
Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
